journal article·2024-07Open access

PAD4 Inhibitor‐Functionalized Layered Double Hydroxide Nanosheets for Synergistic Sonodynamic Therapy/Immunotherapy Of Tumor Metastasis

Di Zhu, Yu Lu, Shuqing Yang, Tingting Hu, Chaoliang Tan, Ruizheng Liang, Yuji Wang

Advanced Science· Volume 11· Issue 26

Abstract

Abstract Sonodynamic therapy (SDT) is demonstrated to trigger the systemic immune response of the organism and facilitate the treatment of metastatic tumors. However, SDT‐mediated neutrophil extracellular traps (NETs) formation can promote tumor cell spread, thus weakening the therapeutic effectiveness of metastatic tumors. Herein, the amorphous CoW‐layered double hydroxide (a‐CoW‐LDH) nanosheets are functionalized with a peptidyl arginine deiminase 4 (PAD4) inhibitor, i.e., YW3‐56, to construct a multifunctional nanoagent (a‐LDH@356) for synergistic SDT/immunotherapy. Specifically, a‐CoW‐LDH nanosheets can act as a sonosensitizer to generate abundant reactive oxygen species (ROS) under US irradiation. After loading with YW3‐56, a‐LDH@356 plus US irradiation not only effectively induces ROS generation and immunogenic cell death, but also inhibits the elevation of citrullinated histone H3 (H3cit) and the release of NETs, enabling a synergistic enhancement of anti‐tumor metastasis effect. Using 4T1 tumor model, it is demonstrated that combining a‐CoW‐LDH with YW3‐56 stimulates an anti‐tumor response by upregulating the proportion of immune‐activated cells and inducing polarization of M1 macrophages, and inhibits immune escape by downregulating the expression of PD‐1 on immune cells under US irradiation, which not only arrests primary tumor progression with a tumor inhibition rate of 69.5% but also prevents tumor metastasis with the least number of lung metastatic nodules.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Photodynamic Therapy Research Studies · Immune cells in cancer

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Medicinal Chemistry College of Pharmaceutical Sciences of Capital Medical University Beijing 100069 P. R. China

State Key Laboratory of Chemical Resource Engineering Beijing Advanced Innovation Center for Soft Matter Science and Engineering Beijing University of Chemical Technology Beijing 100029 P. R. China

Department Electrical and Electronic Engineering The University of Hong Kong Pokfulam Road Hong Kong SAR 999077 P. R. China

Quzhou Institute for Innovation in Resource Chemical Engineering Quzhou 324000 P. R. China

Beijing Area Major Laboratory of Peptide and Small Molecular Drugs Engineering Research Center of Endogenous Prophylactic of Ministry of Education of China Beijing Laboratory of Biomedical Materials, Laboratory for Clinical Medicine, Capital Medical University Beijing Laboratory of Oral Health Beijing 100069 P. R. China

Funding

National Natural Science Foundation of China · Fundamental Research Funds for the Central Universities

References (55)

Show source-provided references
1. 10.1021/jacs.2c1321810.1021/jacs.2c13218 ↗
2. 10.1016/j.nantod.2020.10100410.1016/j.nantod.2020.101004 ↗
3. 10.1038/s41568-020-00300-610.1038/s41568-020-00300-6 ↗
4. 10.1038/nrc372610.1038/nrc3726 ↗
5. 10.1016/j.ccr.2022.21449510.1016/j.ccr.2022.214495 ↗
6. 10.1002/advs.20220654010.1002/advs.202206540 ↗
7. 10.1016/j.ccr.2023.21535010.1016/j.ccr.2023.215350 ↗
8. 10.1038/s41467-023-40826-510.1038/s41467-023-40826-5 ↗
9. 10.1002/adma.20231100210.1002/adma.202311002 ↗
10. 10.1002/advs.20220436510.1002/advs.202204365 ↗
11. 10.3866/PKU.WHXB2010043310.3866/PKU.WHXB20100433 ↗
12. Cui Z. · Chem. Eng. J. · 2023 · 17
13. 10.1002/adma.20221225910.1002/adma.202212259 ↗
14. 10.1002/advs.20200217810.1002/advs.202002178 ↗
15. 10.1002/adma.20220969210.1002/adma.202209692 ↗
16. 10.1038/s41467-023-42509-710.1038/s41467-023-42509-7 ↗
17. 10.1002/advs.20220493210.1002/advs.202204932 ↗
18. 10.1002/adma.20230305910.1002/adma.202303059 ↗
19. 10.1111/imm.1203610.1111/imm.12036 ↗
20. 10.1016/j.copbio.2016.02.00710.1016/j.copbio.2016.02.007 ↗
21. 10.1126/science.aaa620410.1126/science.aaa6204 ↗
22. 10.1002/adma.20180332210.1002/adma.201803322 ↗
23. 10.1038/s41467-020-16191-y10.1038/s41467-020-16191-y ↗
24. 10.1016/j.apsb.2021.11.00610.1016/j.apsb.2021.11.006 ↗
25. 10.1038/nchembio.173510.1038/nchembio.1735 ↗
26. 10.1016/j.immuni.2020.03.00110.1016/j.immuni.2020.03.001 ↗
27. 10.1158/1078-0432.CCR-18-122610.1158/1078-0432.CCR-18-1226 ↗
28. 10.1074/jbc.M112.37572510.1074/jbc.M112.375725 ↗
29. 10.2147/IJN.S25554610.2147/IJN.S255546 ↗
30. 10.2147/IJN.S31921010.2147/IJN.S319210 ↗
31. 10.1039/D2CS00236A10.1039/D2CS00236A ↗
32. 10.1002/adma.20221120510.1002/adma.202211205 ↗
33. Liu W. · Adv. Mater. · 2018 · 30 · 2
34. 10.1002/advs.20200027210.1002/advs.202000272 ↗
35. 10.1021/acsnano.1c0046110.1021/acsnano.1c00461 ↗
36. 10.1002/adma.20170738910.1002/adma.201707389 ↗
37. 10.1038/s41467-018-05223-310.1038/s41467-018-05223-3 ↗
38. 10.1038/s41467-022-31106-910.1038/s41467-022-31106-9 ↗
39. Li T. · Acta Phys. Chim. Sin. · 2020 · 36
40. 10.1021/jacs.8b0865810.1021/jacs.8b08658 ↗
41. 10.1002/smm2.124310.1002/smm2.1243 ↗
42. 10.1002/adma.20200186210.1002/adma.202001862 ↗
43. 10.1002/advs.20220624410.1002/advs.202206244 ↗
44. 10.1016/j.cej.2023.14402810.1016/j.cej.2023.144028 ↗
45. 10.1002/advs.20220720010.1002/advs.202207200 ↗
46. 10.1002/smll.20150335910.1002/smll.201503359 ↗
47. 10.1016/j.biomaterials.2018.05.01510.1016/j.biomaterials.2018.05.015 ↗
48. 10.1016/j.jconrel.2008.05.02110.1016/j.jconrel.2008.05.021 ↗
49. 10.1021/acs.nanolett.0c0477810.1021/acs.nanolett.0c04778 ↗
50. 10.1038/s41467-020-20243-810.1038/s41467-020-20243-8 ↗
51. 10.1158/1541-7786.MCR-19-001810.1158/1541-7786.MCR-19-0018 ↗
52. 10.1002/jbmr.438410.1002/jbmr.4384 ↗
53. 10.3390/biomedicines1002043110.3390/biomedicines10020431 ↗
54. 10.1016/bs.mie.2019.07.02510.1016/bs.mie.2019.07.025 ↗
55. 10.1016/j.coi.2018.03.02310.1016/j.coi.2018.03.023 ↗